Dr. Xiaona Wang is an Associate Professor in the Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University. She obtained her Ph.D. in Neurobiology from Shandong University in 2016 and completed postdoctoral training at Indiana University-Purdue University Indianapolis in 2017. Her research focuses on neurodevelopmental disorders, autism spectrum disorder, epilepsy, intellectual disability, and the neuroprotective effects of drugs against neurological diseases.

She has served as Principal Investigator for projects funded by the National Natural Science Foundation of China and provincial research programs. Dr. Wang has published numerous SCI-indexed articles in high-impact journals and serves as Youth Editor, Academic Editor, Guest Editor, and reviewer for several international journals in pharmacology, neuroscience, and translational medicine.

Dr. Muhammad Ishaq is an Assistant Professor at the Chinese Medicine Guangdong Laboratory (Hengqin), China, specializing in natural products chemistry and bioactive secondary metabolites derived from traditional Chinese medicinal resources. He obtained his Ph.D. from Shanghai Jiao Tong University in 2021 and completed postdoctoral training at Shanghai Jiao Tong University and Guangdong Medical University.

His research expertise includes extraction, isolation, purification, and structural elucidation of natural compounds using advanced analytical techniques such as HPLC, LC-MS, and NMR spectroscopy. He is also experienced in bioinformatics, molecular docking, molecular dynamics simulations, anti-inflammatory and anticancer bioactivity studies, and computational drug discovery.

Dr. Ishaq has published more than 30 SCI-indexed papers and actively collaborates with international researchers. He also serves as a reviewer for peer-reviewed scientific journals and has received several academic awards and research grants.

Prof. Hani A. Alhadrami is a Professor and Consultant of Molecular Diagnostics and Medical Biotechnology at the Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. He also serves as Head of the Nanobiotechnology for Medical Applications Research Group at the King Fahd Medical Research Center and Consultant Scientist at the Special Infectious Agents Unit (BSL-3) at KAU Hospital. He obtained his PhD in Medical Biotechnology from the University of Aberdeen (UK), an MSc in Microbiology and Biotechnology with Commendation, and a Diploma in Medical Education from KAU. Prof. Alhadrami is an inventor of multiple U.S. patents and has published over 100 peer-reviewed articles. His work focuses on molecular diagnostics, biosensing technologies, nanomedicine, and infectious disease diagnostics.

Dr. Ismael Valladolid-Acebes is Group Leader and Director of the Signal Transduction Unit at the Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital in Stockholm. He holds a Licentiate in Pharmacy, an MPhil in Pharmacology, a PhD in Medical Science, and an MS in Clinical Research from Spanish universities. His research focuses on molecular and cellular mechanisms regulating metabolic and endocrine homeostasis, especially pancreatic islet biology, insulin secretion, metabolic stress pathways, and diabetes and its complications. He has published more than 40 scientific articles and is actively involved in teaching, supervision, and international academic service.

Dr. Josiana Adelaide Vaz is an Adjunct Professor at the Polytechnic Institute of Bragança and a Researcher at the LiveWell Centre for Active Living and Wellbeing. She holds a PhD in Pharmaceutical Sciences from the University of Porto. Her multidisciplinary career covers biomedical laboratory sciences, pharmacology, natural products and medical biotechnology. Her main research focuses on bioactive compounds from wild mushrooms and plants, antioxidant and antiproliferative activity, biomonitoring of environmental and occupational exposure, sericin-based biomaterials and sleep-related health determinants. She has authored over 50 scientific works, collaborated with more than 100 researchers and participates in several funded projects including IberLongeva, NSL – New Long-lived Societies, Bio4Drinks and Acorn4Med. She also holds multiple academic governance roles.

Prof. Hamdy Abdelkader is a Professor in Pharmaceutics at the College of Pharmacy, King Khalid University, KSA. He is a Fellow of the Higher Education Academy (UK). His academic career spans Africa, Asia, Oceania, and Europe. He received his BPharm from Alexandria University (2000) and PhD from the University of Auckland, New Zealand (2011). He was awarded the prestigious Leverhulme Fellowship in the UK (2013–2015). His research focuses on ocular drug delivery and age-related eye diseases. He has served as Associate Editor-in-Chief for JABPS and is on editorial boards of multiple journals. He has lectured internationally, including in Egypt and the UK.

Dr. Krishna Chandra Panda is an Associate Professor in the Faculty of Pharmacy at Roland Institute of Pharmaceutical Sciences, Berhampur, Odisha, with 17 years of teaching and research experience. He earned his Ph.D. in Pharmacy from Biju Patnaik University of Technology and has published more than 30 international and 10 national research papers, 8 book chapters, 3 authored books, and 2 Indian patents.

His research focuses on medicinal and heterocyclic chemistry, green chemistry, drug design, phytochemical screening, neurobiology, and biological evaluation of bioactive compounds. He also serves as a reviewer/editorial member for various international journals and is a life member of APTI.

Mohamed Ashraf Momtaz is an experienced analytical chemist with over 13 years in pharmaceutical research and development. He specializes in advanced chromatographic and electrochemical methods supporting therapeutic drug monitoring, pharmacokinetics, and innovative drug detection platforms.

He has contributed significantly to method validation, stress stability studies, and bioequivalence research for various dosage forms, aligning with global regulatory standards (USP, BP, ICH). As Associate Manager of Laboratories Development at EIPICO, he leads multidisciplinary teams and collaborates with CROs to drive pharmaceutical innovation and regulatory compliance.

He is currently pursuing a Ph.D. in Analytical Chemistry at Tanta University and actively reviews peer-reviewed journal submissions, further advancing research quality standards in the pharmaceutical industry.

Prof. Aura Rusu is a Full Professor at the Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania. Her academic journey spans more than two decades, with advanced qualifications in Pharmacy, Quality Management, and Drug Design. She coordinates courses in Pharmaceutical and Therapeutic Chemistry, Medicinal Chemistry, and Drug Design.
Her research interests focus on pharmaceutical and medicinal chemistry, antibacterial agents, metal complexes, analytical chemistry, and drug design.
She has authored 14 books and over 80 peer-reviewed papers (Impact Factor: 142.69, H-index: 18), serves as a reviewer for more than 30 international journals, and has been Guest Editor for MDPI journals such as Pharmaceutics, Molecules, and Cosmetics.